In the article by Borlaug et al, “Latent Pulmonary Vascular Disease May Alter the Response to Therapeutic Atrial Shunt Device in Heart Failure,” which published in the May 24, 2022, issue of the journal (Circulation.2022; 145:1592-1604. DOI: 10.1161/CIRCULATIONAHA.122.059486), a correction is needed. The disclosures of one the authors, Dr Scott Solomon, was inadvertently excluded from the disclosures statement in the manuscript. They are as follows:

“Dr Solomon has received research grants from Actelion, Alnylam, Amgen, AstraZeneca, Bellerophon, Bayer, BMS, Celladon, Cytokinetics, Eidos, Gilead, GSK, Ionis, Lilly, Mesoblast, MyoKardia, NIH/NHLBI, Neurotronik, Novartis, NovoNordisk, Respicardia, Sanofi Pasteur, Theracos, US2.AI and has consulted for Abbott, Action, Akros, Alnylam, Amgen, Arena, AstraZeneca, Bayer, Boeringer-Ingelheim, BMS, Cardior, Cardurion, Corvia, Cytokinetics, Daiichi-Sankyo, GSK, Lilly, Merck, Myokardia, Novartis, Roche, Theracos, Quantum Genomics, Cardurion, Janssen, Cardiac Dimensions, Tenaya, Sanofi-Pasteur, Dinaqor, Tremeau, CellProThera, Moderna, American Regent, Sarepta, Lexicon, Anacardio, Akros, Puretech Health.”

The correction has been made to the current online version of the article, which is available at https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059486.

在 Borlaug 等人的文章中，“潜伏性肺血管疾病可能改变对治疗性心房分流装置在心力衰竭中的反应”，该文章发表在 2022 年 5 月 24 日的期刊(Circulation. 2022; 145:1592-1604) 上. DOI: 10.1161/CIRCULATIONAHA.122.059486)，需要更正。作者之一 Scott Solomon 博士的披露无意中被排除在手稿的披露声明之外。它们如下：

“所罗门博士获得了来自 Actelion、Alnylam、Amgen、AstraZeneca、Bellerophon、Bayer、BMS、Celladon、Cytokinetics、Eidos、Gilead、GSK、Ionis、Lilly、Mesoblast、MyoKardia、NIH/NHLBI、Neurotronik、Novartis、NovoNordisk、 Respicardia、Sanofi Pasteur、Theracos、US2.AI 并为 Abbott、Action、Akros、Alnylam、Amgen、Arena、AstraZeneca、Bayer、Boeringer-Ingelheim、BMS、Cardior、Cardurion、Corvia、Cytokinetics、Daiichi-Sankyo、GSK、礼来、默克、Myocardia、诺华、罗氏、Theracos、Quantum Genomics、Cardurion、Janssen、Cardiac Dimensions、Tenaya、赛诺菲-巴斯德、Dinaqor、Tremeau、CellProThera、Moderna、American Regent、Sarepta、Lexicon、Anacardio、Akros、Puretech Health。 ”

已对文章的当前在线版本进行了更正，该版本可在 https://www.ahajournals.org/doi/10.1161/CIRCULATIONAHA.122.059486 获得。